Abstract

ObjectiveTo validate the targeted next-generation sequencing (NGS) platform-Ion Torrent PGM for KRAS exon 2 and expanded RAS mutations detection in formalin-fixed paraffin-embedded (FFPE) colorectal cancer (CRC) specimens, with comparison of...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Comprehensive analysis of KRAS and NRAS mutations as predictive biomarkers for single agent panitumumab (pmab) response in a randomized, phase III metastatic colorectal cancer (mCRC) study (20020408).
Scott D Patterson ... Kelly S Oliner
Journal of Clinical Oncology | VOL. 31
Scott D Patterson, et. al.Scott D Patterson ... Kelly S Oliner
20 May 2013
FOLFOX4 plus cetuximab administered weekly or every two weeks in first-line treatment of patients with KRAS and NRAS wild-type (wt) metastatic colorectal cancer (mCRC).
Thomas Brodowicz ... Christoph Zielinski
Journal of Clinical Oncology | VOL. 32
Thomas Brodowicz, et. al.Thomas Brodowicz ... Christoph Zielinski
20 Jan 2014
Targeted data-independent acquisition for mass spectrometric detection of RAS mutations in formalin-fixed, paraffin-embedded tumor biopsies
Yeoun Jin Kim ... Todd Hembrough
Journal of Proteomics | VOL. 189
Yeoun Jin Kim, et. al.Yeoun Jin Kim ... Todd Hembrough
22 Apr 2018
Exploratory RAS analysis of the phase Ib/II 20060447 trial of rilotumumab (R) or ganitumab (G) plus panitumumab (pmab) versus pmab alone in patients (pts) with previously treated metastatic colorectal cancer (mCRC).
Cathy Eng ... Kelly Smith Oliner
Journal of Clinical Oncology | VOL. 33
Cathy Eng, et. al.Cathy Eng ... Kelly Smith Oliner
20 Jan 2015
View more papers

More From: BMJ Open

Paper Title
Journal
Date
Author
Efficacy and safety of henagliflozin combined with continuous subcutaneous insulin infusion in the treatment of Chinese inpatients with type 2 diabetes mellitus based on a continuous glucose monitoring system: protocol of a multicentre, open-label, inpatient, randomised, controlled trial
Yingling Wu ... Yingfen Qin
BMJ Open | VOL. 14
Yingling Wu, et. al.Yingling Wu ... Yingfen Qin
11 Oct 2024
Disclosure of medical errors to patients by medical professionals: a protocol for a qualitative systematic review
Guiru Chen ... Henyu Xiong
BMJ Open | VOL. 14
Guiru Chen, et. al.Guiru Chen ... Henyu Xiong
11 Oct 2024
No one left to cope alone (NOLA): protocol for the development of a postdiagnostic intervention to support people newly diagnosed with dementia
Charlotte R Stoner ... Aimee Spector
BMJ Open | VOL. 14
Charlotte R Stoner, et. al.Charlotte R Stoner ... Aimee Spector
11 Oct 2024
Metronomic chemotherapy for paediatric extracranial solid tumours: a systematic review and meta-analysis of randomised clinical trials
Frank Peinemann ... Marc Hoemberg
BMJ Open | VOL. 14
Frank Peinemann, et. al.Frank Peinemann ... Marc Hoemberg
11 Oct 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.